Valiant Laboratories Ltd share price logo

Valiant Laboratories Ltd Share Price (VALIANTLAB)

Check the latest share price of Valiant Laboratories Ltd, along with the price target, peer comparison, quarterly results, recent news, expert analysis, shareholding pattern, and other key fundamentals to make informed investment decisions.

₹119.974.71%

as on 04:01PM, 13 Jun 2025

NSE

bell
The current prices are delayed by 15 mins, login to check live prices.

Valiant Laboratories Ltd Stock Performance

Get live Valiant Laboratories Ltd share price, day's high and low, historical returns, and market stats.

  • Day's Low

    Day's High

    ₹112.25
    Day's Price Range
    ₹120.29
  • 52 Week's Low

    52 Week's High

    ₹75.2
    52-Week Price Range
    ₹157.49
1 Month Return+ 17.2 %
3 Month Return+ 49.18 %
1 Year Return-18.11 %
3 Year Return-29.53 %
5 Year Return-29.53 %
Previous Close₹114.57
Open₹114.57
Volume3.42L
Upper Circuit₹120.29
Lower Circuit₹108.84

Valiant Laboratories Ltd Fundamentals & Key Indicators

Check Valiant Laboratories Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

₹6.24 Cr

Return on Equity (ROE)

0

PE Ratio (TTM)

0

Return on capital employed (ROCE)

0

Industry PE ratio

57.39

Beta (LTM)

0.32

P/B Ratio

-0.04

Dividend Yield

0

PEG Ratio

0

Quarterly Earnings Growth YOY

-156.45

EPS (TTM)

0

Sector

Pharmaceuticals

Book Value

54.51

Technical Analysis

How to invest in Valiant Laboratories Ltd?

Investing in Valiant Laboratories Ltd is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Valiant Laboratories Ltd or VALIANTLAB on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

For example: You can buy 10 shares of Valiant Laboratories Ltd or start an SIP based on the market price on each investment date.
You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Valiant Laboratories Ltd with just a few clicks!

Valiant Laboratories Ltd Stock's Interest Amongst Investors

62%

Period Jun 14, 2025 to May 15, 2025. Change in 30 Days vs previous period

Search interest for Valiant Laboratories Ltd Stock has increased by 62% in the last 30 days, reflecting an upward trend in search activity.

Valiant Laboratories Ltd Valuation

Track how Valiant Laboratories Ltd P/E has moved over time to understand its valuation trends.

Valiant Laboratories Ltd in the last 5 years

  • Overview

  • Trends

Lowest (-230.71x)

June 13, 2025

Today (-230.71x)

June 13, 2025

Industry (57.39x)

June 13, 2025

Highest (413.29x)

April 10, 2024

LowHigh

Today’s Price to Earnings Ratio: -230.71x

Valiant Laboratories Ltd Financial Results

Get the annual and quarterly financial summary of Valiant Laboratories Ltd, including revenue, profit, loss and more.

Value in ₹ crore
DetailsQ4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25
Revenue

(in ₹ Cr)

31 (0%)19 (38%)21 (14%)35 (64%)58 (64%)
Net Income

(in ₹ Cr)

-1 (0%)-1 (59%)-5 (829%)2 (150%)1 (70%)
Net Profit Margin-4.05% (0%)-2.70% (33%)-22.07% (717%)6.67% (130%)1.21% (82%)
Value in ₹ crore
DetailsFY21FY22FY23FY24
Total Assets

(in ₹ Cr)

106 (0%)182 (71%)213 (17%)325 (53%)
Total Liabilities

(in ₹ Cr)

18 (0%)110 (522%)112 (2%)89 (21%)
Value in ₹ crore
DetailsFY21FY22FY23FY24
Operating Cash Flow

(in ₹ Cr)

9 (0%)2 (75%)23 (920%)49 (112%)

Valiant Laboratories Ltd Earnings and Dividends

View detailed summary of the earnings and dividend history of Valiant Laboratories Ltd.

  • Valiant Laboratories Ltd Earnings Results

    Valiant Laboratories Ltd’s net profit jumped 156.45% since last year same period to ₹0.70Cr in the Q4 2024-2025. On a quarterly growth basis, Valiant Laboratories Ltd has generated -70.21% fall in its net profits since last 3-months.

    Read More about Earnings Results

Valiant Laboratories Ltd Shareholding Pattern

View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Valiant Laboratories Ltd.

InvestorsHoldings %Quarterly Trend3M change
Promoter Holdings
74.94%
0.00
Foreign Institutions
0.64%
0.00
Mutual Funds
0%
0.00
Retail Investors
24.42%
0.00
Others
0%
0.00

Valiant Laboratories Ltd vs Peers

Compare market cap, revenue, PE, and other key metrics of Valiant Laboratories Ltd with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
NA6.245.19%5.69NANA
NA81.5858.65%0.51140
NA1,949.0625.81%0.5158630
NA69.916.88%0.78245
NA375.2830.71%0.51NANA

Valiant Laboratories Ltd News & Key Events

Latest news and events in one place to help you make informed investing decisions in Valiant Laboratories Ltd.

  • Valiant Lab Reports Strong Financial Growth - 22 May, 2025

    Valiant Lab's consolidated net sales for March 2025 reached Rs 57.79 crore, up 88.92% year-on-year. Net profit increased by 156.77% to Rs 0.70 crore, while EBITDA rose 174.38% to Rs 1.51 crore. EPS decreased to Rs 0.16 from Rs 0.33 in March 2024. Shares closed at Rs 103.63 on May 20, 2025.
  • Valiant Laboratories Reports Strong Q4 Performance - 21 May, 2025

    Valiant Laboratories posted a consolidated net profit of Rs 0.70 crore for the March 2025 quarter, a significant recovery from a loss. Sales surged 88.92% to Rs 57.79 crore compared to the previous year.

Insights on Valiant Laboratories Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, VALIANTLAB stock has moved up by 9.9%

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 4 quarters, 21.7 Cr → 55.47 Cr (in ₹), with an average increase of 26.3% per quarter

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 0.00% to 0.64% in Mar 2025 quarter

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 74.94% of holdings in Mar 2025 quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 2.35 Cr → 0.7 Cr (in ₹), with an average decrease of 70.2% per quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 25.06% to 24.42% in Mar 2025 quarter

About Valiant Laboratories Ltd

Valiant Laboratories Limited was originally formed as a Partnership Firm under the name and style of M/s. Bharat Chemicals through Deed of Partnership dated October 17 1980. The said Partnership Firm M/s. Bharat Chemicals thereafter converted into a Public Limited Company with the name Valiant Laboratories Limited through certificate of incorporation dated August 16 2021 issued by the Central Registration Centre Registrar of Companies.The Company is an Active Pharmaceutical Ingredient API / Bulk Drug manufacturing company having focus on manufacturing of Paracetamol. The Company gradually commenced manufacturing of Paracetamol by late 1982. Paracetamol Scientific name: Acetaminophen or parahydroxyacetanilide C8H9NO2 is one of the most commonly taken analgesic worldwide and is recommended as the firstline therapy in pain conditions by the World Health Organization WHO. Paracetamol has several applications such as usage in treatment of headaches muscle aches arthritis back aches toothaches cold and fever. It manufacture Paracetamol in various grades such as IP/BP/EP/USP as per the pharmacopeia requirements of customers.Paracetamol is available in a variety of forms including syrup form regular tablets effervescent tablets injection suppository and other forms. Paracetamol is often found combined with other drugs in many over the counter OTC allergy medications cold medications sleep medications pain relievers and other products. Presently the Company is engaged in manufacturing and dealing in Pharmaceuticals and specility chemicals. The manufacturing facility is located at Tarapur Industrial Area Boisar in the State of Maharashtra with an annual installed capacity of 9000 MTPA. Within the Manufacturing Facility located at Tarapur Industrial Area Palghar Maharashtra the Company has an inhouse RD infrastructure which is equipped with analytical laboratory and infrastructure for developmental activities in existing product. The Company is promoted by Shantilal Shivji Vora Director and Dhanvallabh Ventures LLP DVL. In July 2022 the Company formed its wholly owned subsidiary Valiant Advanced Sciences Private Limited VASPL to diversify the business activities.The Company has come out with a Public Issue of issuing upto 11556000 Equity Shares through fresh issue..

Revenue: ₹57.79Cr as on March 2025 (Q4 FY25)
Net Profit: ₹0.70Cr as on March 2025 (Q4 FY25)
Listing date: 06 Oct, 2023
Chairperson Name: Velji Gogri
OrganisationValiant Laboratories Ltd
IndustryPharmaceuticals
CEOVelji Gogri
E-voting on sharesClick here to vote

FAQs

What is Valiant Laboratories Ltd share price today?

Valiant Laboratories Ltd share price today stands at ₹119.97, Open: ₹114.57, Previous Close: ₹114.57, High: ₹120.29, Low: ₹112.25, 52 Week High: ₹157.49, 52 Week Low: ₹75.2.

What is today's traded volume of Valiant Laboratories Ltd?

Today's traded volume of Valiant Laboratories Ltd is 3.42L. Which means that 3.42L shares of Valiant Laboratories Ltd were bought and sold on the stock market during today's trading session.

What is Valiant Laboratories Ltd's market cap today?

Today's market capitalisation of Valiant Laboratories Ltd is ₹521.27 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.

What is the 52 week high and 52 week low range of Valiant Laboratories Ltd?

Valiant Laboratories Ltd’s 52 week high is ₹157.49 and 52 week low is ₹75.2. The current share price of Valiant Laboratories Ltd is ₹119.97, which is -23.82% down from its 52 week high and 59.53% up from its 52 week low.